Lario Therapeutics: Funding, Investors & Team (Sep 2026)
Lario Therapeutics is a company specializing in creating targeted treatment options for epilepsy and neurological conditions.
Lario Therapeutics has raised $8.5M across 2 funding rounds on record, the most recent an undisclosed round of $2.4M announced in Feb 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Lario Therapeutics Company Profile and Key Stats
Latest funding round on record: Feb 2026.
Lario Therapeutics Funding Rounds
Lario Therapeutics raised $6.1M in an undisclosed round announced in Jul 2024.
1.6 years later, an undisclosed round of $2.4M was announced in Feb 2026.
Lario Therapeutics Founders and Leadership Team
Contact details for the Lario Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Lario Therapeutics Funding Compared to Other Biotechnology Startups
Lario Therapeutics' latest round of $2.4M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Lario Therapeutics in Biotechnology and Edinburgh
Companies Similar to Lario Therapeutics
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
IMU is a discovery engine mapping the immune system to advance precision medicine.
Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…
Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…
Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…
Five is a biometric payment services company that offers thumb recognition technology for safe transactions.
Lario Therapeutics Funding FAQs
What does Lario Therapeutics do?
Lario Therapeutics is a company specializing in creating targeted treatment options for epilepsy and neurological conditions.
How much funding has Lario Therapeutics raised?
Lario Therapeutics has raised $8.5M across 2 rounds on record. The most recent is an undisclosed round of $2.4M announced in Feb 2026.
When did Lario Therapeutics last raise funding?
Lario Therapeutics' most recent funding round on record is an undisclosed round of $2.4M, announced in Feb 2026.
Who founded Lario Therapeutics?
FundedIQ lists Daniel Gill (Founder) at Lario Therapeutics.
Where is Lario Therapeutics headquartered?
Lario Therapeutics is based in Edinburgh, United Kingdom.
How many employees does Lario Therapeutics have?
Lario Therapeutics is in the 1-10 employee band.
How does Lario Therapeutics' funding compare to other Biotechnology startups?
Lario Therapeutics' latest round of $2.4M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Lario Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Lario Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.